Improving the quality of life for patients with functional mitral regurgitation

GizaVC invests in the vision of most innovative entrepreneurs.


Mitralign is developing an innovative catheter-based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system  rivals surgical annuloplasty.

mitralign c


Corporate Headquarters

Address:  3 Highwood Drive, Suite 200E, Tewksbury, Massachusetts 01876 USA

F: +1-978-858-0160


CEO: Rick Geoffrion          COO/CFO: Richard J. Omilanowicz

Giza's Team Member

Yuval Avni



Fields of invesment: icon lifeHealthcare

Contact info: Website